CCS adapting to COVID-19 realities to support Canadians during and after the pandemic
Stay informed and inspired!
Subscribe to our monthly e-newsletter×
Induced pluripotent stem cells are made from skin or blood cells that are reprogrammed to become any cell type in the body, making them great targets for regenerative medicine. However, scientists from Stanford University found that IPS cells look and act just like cancer cells, making them potential cancer vaccines. By injecting mice first with a vaccine made of IPS cells then with cancer cells, the mouse’s immune system got a head-start on recognizing cancer cells by launching an immune response early against the IPS cells. Learn more in an article from the Los Angeles Times.